Published in Alzheimers Res Ther on December 05, 2014
A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease | NCT01944436
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron (2002) 33.99
Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage (2002) 29.63
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A (2000) 19.87
Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp (2000) 15.98
A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp (1996) 13.15
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Bayesian analysis of neuroimaging data in FSL. Neuroimage (2008) 9.10
Cornell Scale for Depression in Dementia. Biol Psychiatry (1988) 6.61
The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology (1997) 6.33
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet (2000) 4.37
The lateral occipital complex and its role in object recognition. Vision Res (2001) 4.01
Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment (1999) 3.47
The evolution and pathology of frontotemporal dementia. Brain (2005) 3.46
Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol (2003) 3.22
Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology (2003) 3.07
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther (1999) 2.53
Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology (2007) 2.09
Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 1.99
Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn (1992) 1.98
The cortical localization of the lexicons. Positron emission tomography evidence. Brain (1992) 1.91
More accurate Talairach coordinates for neuroimaging using non-linear registration. Neuroimage (2008) 1.90
Clinicopathological correlations in corticobasal degeneration. Ann Neurol (2011) 1.86
Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain (2006) 1.86
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology (2000) 1.85
Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology (1999) 1.84
Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology (1999) 1.70
Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol (2001) 1.67
FMRI of visual encoding: reproducibility of activation. Hum Brain Mapp (2000) 1.46
Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls. Mov Disord (1995) 1.43
Functional networks for cognitive control in a stop signal task: independent component analysis. Hum Brain Mapp (2011) 1.43
The aphasia quotient: the taxonomic approach to measurement of aphasic disability. Can J Neurol Sci (1974) 1.36
Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology (1999) 1.36
Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology (2001) 1.34
Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology (1996) 1.32
Accuracy of the clinical evaluation for frontotemporal dementia. Arch Neurol (2007) 1.29
Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord (2003) 1.27
Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov Disord (2004) 1.27
Differential effects of word length and visual contrast in the fusiform and lingual gyri during reading. Proc Biol Sci (2000) 1.24
The many faces of corticobasal degeneration. Parkinsonism Relat Disord (2007) 1.22
Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial. Ann Neurol (2012) 1.19
A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging (2002) 1.19
Lesion Explorer: a comprehensive segmentation and parcellation package to obtain regional volumetrics for subcortical hyperintensities and intracranial tissue. Neuroimage (2010) 1.19
Structural brain correlates of response inhibition in Bipolar Disorder I. J Psychopharmacol (2008) 1.18
A robust method for extraction and automatic segmentation of brain images. Neuroimage (2002) 1.17
Boston Naming Test in Alzheimer's disease. Neuropsychologia (1989) 1.15
Default network connectivity during a working memory task. Hum Brain Mapp (2010) 1.13
99mTc-ECD brain perfusion SPET: variability, asymmetry and effects of age and gender in healthy adults. Eur J Nucl Med (2001) 1.12
Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology (1998) 1.09
Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp Neurol (2000) 1.09
Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography. Neurosci Lett (1997) 1.06
The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry (1991) 1.05
Visuospatial functions in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry (2006) 1.05
Executive dysfunction in frontotemporal dementia and corticobasal syndrome. Neurology (2009) 1.03
Corticobasal degeneration. Lancet Neurol (2004) 1.01
Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. Int J Geriatr Psychiatry (2004) 1.01
Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology (1999) 0.98
A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med (1995) 0.97
Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies. Eur J Nucl Med Mol Imaging (2002) 0.96
Corticobasal degeneration and progressive aphasia. Neurology (2006) 0.96
Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies. Neurology (2000) 0.94
Early diagnosis of the frontal variant of frontotemporal dementia: how sensitive are standard neuroimaging and neuropsychologic tests? Neuropsychiatry Neuropsychol Behav Neurol (1999) 0.93
Three brain SPECT region-of-interest templates in elderly people: normative values, hemispheric asymmetries, and a comparison of single- and multihead cameras. J Nucl Med (2000) 0.93
The California Verbal Learning Test: psychometric characteristics and clinical application. Neuropsychol Rev (1995) 0.92
Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia. Expert Rev Neurother (2011) 0.91
Lingual and fusiform gyri in visual processing: a clinico-pathologic study of superior altitudinal hemianopia. J Neurol Neurosurg Psychiatry (1987) 0.91
Chromaticity of color perception and object color knowledge. Neuropsychologia (2011) 0.90
Parieto-occipital cortex activation during self-generated eye movements in the dark. Brain (1998) 0.86
A 99mTc-HMPAO single-photon emission computed tomography study of Lewy body disease. J Neurol (1997) 0.86
Where color rests: spontaneous brain activity of bilateral fusiform and lingual regions predicts object color knowledge performance. Neuroimage (2013) 0.85
Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. J Neuropsychiatry Clin Neurosci (2007) 0.84
Voxel-based distribution of metabolic impairment in corticobasal degeneration. Mov Disord (2000) 0.84
SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. J Nucl Med (1997) 0.84
Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN). J Alzheimers Dis (2010) 0.83
Dementia with Lewy bodies. Aust N Z J Psychiatry (1999) 0.82
Cerebral blood flow correlates of higher brain dysfunctions in corticobasal degeneration. J Geriatr Psychiatry Neurol (1999) 0.78
Spatial normalization of lesioned HMPAO-SPECT images. Neuroimage (2001) 0.78
Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET. Nucl Med Commun (2001) 0.77
Diffuse lewy body disease presenting as corticobasal syndrome and progressive supranuclear palsy syndrome. Mov Disord (2013) 0.76
Neuropsychological and neuroimaging correlates in corticobasal degeneration. Ital J Neurol Sci (1998) 0.76
Comparison of brain perfusion in corticobasal degeneration and Alzheimer's disease. Dement Geriatr Cogn Disord (2001) 0.76